This trial is evaluating whether interactive 3D tool will improve 1 secondary outcome in patients with Breast Cancer. Measurement will happen over the course of 3 months after surgery.
This trial requires 60 total participants across 2 different treatment groups
This trial involves 2 different treatments. Interactive 3D Tool is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"The interactive 3D-technique was found to be more effective than a placebo to improve [pain management](https://www.withpower.com/clinical-trials/pain-management) during treatment for breast cancer/mastectomy. Patients were able to gain greater confidence that their pain would lessen while being treated with the tool, therefore a reduction in the amount of pain medication was observed." - Anonymous Online Contributor
"The signs of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) may include: lump in the breast, tingling or swelling on part of the breast, new growth, nipple discharge when not breastfeeding, change in menstrual bleeding patterns, unusual bleeding which lasts longer than normal, unexplained weight loss, unexplained pain which goes away the next day, or a lump or tenderness in the breast." - Anonymous Online Contributor
"Different types of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) have different causes, and there are specific causes of each type. While some genetic changes appear to be common to all breast cancers, others are specific to individual cancers. Tobacco smoking is the most common cause of breast cancer, and it may be more damaging for the women who develop breast cancer. At a basic level, breast cancer occurs because breast cells have problems with their DNA." - Anonymous Online Contributor
"Breast cancer is a type of cancer that forms in the breast and also typically appears in women over the age of 50. It is the leading cause of cancer death in women in developed countries." - Anonymous Online Contributor
"Although [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) has a five-year cure rate of about 90%, this does not mean all women will be fully healed after treatment. Most women with advanced stage breast cancer are still severely affected when they have not had an active and curative treatment as defined by the American Society of Clinical Oncology, 2007. Most women with stage 3 cancers have more than a 75% chance of metastasis at diagnosis and, among those with localized cancer, over 80% will develop metastases within 10 years. Many women with stage 3 cancer will have to be in long-term (years) care to manage their disease and will not be cured. Treatment should be focused on eliminating symptoms with optimal dose of the treatment and supportive measures." - Anonymous Online Contributor
"Breast cancer is the most common type of benign cancer. Although treatment for [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) is highly dependent on the specific subtype, there is some consensus that lumpectomy is the most acceptable alternative to mastectomy without the need for adjuvant therapy if breast sparing mastectomy is undertaken." - Anonymous Online Contributor
"around 70,000 women develop breast cancer annually in the U.S. The U.S. Preventive Services Task Force (USPSTF) panel found, however, insufficient evidence to assess the use of mammography in the primary screening for breast cancer in the United States." - Anonymous Online Contributor
"The first cancer researcher to perform in vitro and clinical trials for breast cancer and other tumors was George Wald in 1924. This is the first time, however, there is any proof for the role of this researcher in the disease. The first chemotherapeutic agent to eliminate breast cancer was the taxane family of drugs in 1977. It has been shown in multiple clinical trials that there seems to be a significant improvement in breast cancer survival by using these new compounds. One compound shows to be the very first drug approved by the U.S. Food and Drug Administration to treat metastatic breast cancer patients. Also, for women with estrogen receptor-negative disease, tamoxifen has demonstrated improvements in relapse-free survival and overall survival in some studies." - Anonymous Online Contributor
"Breast cancer may be associated with a combination of risk factors. In other words, a number of environmental risk factors and genetic predispositions are believed to be most strongly related to developing breast cancer. However, in many patients, there is little or no relation between a patient’s genetic predisposition and her cancer risks or patterns of breast cancer. Nevertheless, in some patients with a relatively modest number of risk factors and without a strong genetic predisposition, breast cancer may develop even in the absence of environmental risk factors. It is in these patients with fewer risk factors that breast cancer may manifest as a less aggressive disease." - Anonymous Online Contributor
"Overall, the majority of patients undergoing IGRT were provided with some additional treatment. This appears to be more prevalent in patients who have larger lesions and tumors>4 cm but not with regards to the other features." - Anonymous Online Contributor
"It can effectively visualize the morphology of mammary tumors and their metastatic spread. It provides a unique and interactive visualization tool for a range of surgical surgeons. An improvement of the software is feasible." - Anonymous Online Contributor
"The American Cancer Society states that the median age at diagnosis is 62. Breast cancer occurs at varying ages at different rates by country.\n\nIndia\nIt has been found that it affects more women in developing countries.\n\nIndia: The National Cancer Registry Program (NCRP) has recently published results from the first analysis of incidence and mortality rates over a 10-year period (~2002–2012). Data from a recent study showed that breast cancer incidence was increasing drastically. There are many causes, some of which have to do with the lifestyle and environment of the country including diet, smoking, weight gain and BMI." - Anonymous Online Contributor